載入...
Immunologic alterations in the pancreatic cancer microenvironment of patients treated with neoadjuvant chemotherapy and radiotherapy
Pancreatic ductal adenocarcinoma (PDAC) has dismal 5-year survival (<9%). We hypothesize that exposure of tumors to conventional therapies may preferentially modulate immune biomarkers in the tumor microenvironment in PDAC. PDAC patients who underwent upfront surgical resection or who received ne...
Na minha lista:
| 發表在: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Clinical Investigation
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7030821/ https://ncbi.nlm.nih.gov/pubmed/31830001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.130362 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|